Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Eli Lilly and Company - Wikipedia

    en.wikipedia.org/wiki/Eli_Lilly_and_Company

    Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.

  3. List of largest selling pharmaceutical products - Wikipedia

    en.wikipedia.org/wiki/List_of_largest_selling...

    3 Largest selling pharmaceutical products of 2015. 4 Best selling pharmaceuticals of 2013. ... Eli Lilly and Company: Diabetes mellitus type 1 and 2: Apr-1996: Mon ...

  4. Abelardo Aguilar - Wikipedia

    en.wikipedia.org/wiki/Abelardo_Aguilar

    Philippines. Occupation. Physician. Known for. Discovery of erythromycin. Abelardo Aguilar (November 3, 1917 – September 22, 1993 was a Filipino doctor from Iloilo, Philippines who worked as a medical representative for Eli Lilly and Company. [1] [2]

  5. Weight loss, diabetes drugs propel Eli Lilly to largely ...

    www.aol.com/news/weight-loss-diabetes-drugs...

    The popular diabetes treatment Mounjaro pushed Eli Lilly past fourth-quarter forecasts, and the drugmaker predicted that 2024 will turn out largely better than expected too as new products build ...

  6. Weight-loss drug drives Eli Lilly to raise 2024 sales ... - AOL

    www.aol.com/news/eli-lilly-lifts-profit-view...

    Eli Lilly raised both ends of its 2024 revenue forecast by $2 billion and now expects $42.4 billion to $43.6 billion for the year. The drugmaker also raised its annual profit forecast by $1.30 per ...

  7. Eli Lilly exec on weight-loss drugs: 'It's not just a flash ...

    www.aol.com/finance/eli-lilly-exec-weight-loss...

    Eli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound — which Wall Street estimates could net the company $13.5 billion in 2024 — but the success comes ...

  8. Tirzepatide - Wikipedia

    en.wikipedia.org/wiki/Tirzepatide

    Tirzepatide is a GIP receptor and glucagon-like peptide-1 agonist. [11] The most common side effects include nausea, vomiting, diarrhea, decreased appetite, constipation, upper abdominal discomfort, and abdominal pain. [10] [13] [17] Tirzepatide was approved for treatment of diabetes in the United States in May 2022, [10] [13] in the European ...

  9. Boehringer Ingelheim - Wikipedia

    en.wikipedia.org/wiki/Boehringer_Ingelheim

    Website. boehringer-ingelheim .com. C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one.